Eupraxia Pharmaceuticals (EPRX) Ending Cash Balance (2022 - 2026)
Eupraxia Pharmaceuticals (EPRX) reported Ending Cash Balance of $52.43 million for Q2 2026, up 165.2% from $19.77 million a year earlier but down 10.4% from the prior quarter.
Powered by 
Analysis
Eupraxia Pharmaceuticals (EPRX) Ending Cash Balance (2022 - 2026) Analysis & Trends
For FY2025, Eupraxia Pharmaceuticals posted Ending Cash Balance of $80.56 million, up 143.4% from FY2024.
- Ending Cash Balance has increased for three consecutive years, with a three-year compound annual growth rate of 64.0% (FY2022 to FY2025).
- By year, Ending Cash Balance came in at $33.1 million in FY2024 (+71.1%), $19.34 million in FY2023 (+5.9%) and $18.26 million in FY2022.
- Five-year quarterly Ending Cash Balance spans a low of $8.66 million in Q3 2024 and a high of $88.96 million in Q3 2025.
- Year over year, Ending Cash Balance has now increased in each of the last four quarters, with growth averaging 164.5% over the last eight quarters.
- The high point for year-over-year Ending Cash Balance in five years was Q3 2025 (growth of 927.0%); the low point was Q3 2024 (a decline of 64.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $58.5 million (Q1 2026), $80.56 million (Q4 2025) and $88.96 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Ending Cash Balance (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.65 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.88 Bn |
| 10 | Eupraxia Pharmaceuticals | 304.87 Mn | -174.66 Mn | - | 75.18 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 75.18 Mn |
| Jun 30, 2026 | 52.43 Mn |
| Mar 31, 2026 | 58.50 Mn |
| Dec 31, 2025 | 80.56 Mn |
| Sep 30, 2025 | 88.96 Mn |
| Jun 30, 2025 | 19.77 Mn |
| Mar 31, 2025 | 27.45 Mn |
| Dec 31, 2024 | 33.10 Mn |
| Sep 30, 2024 | 8.66 Mn |
| Jun 30, 2024 | 23.32 Mn |
| Mar 31, 2024 | 35.91 Mn |
| Dec 31, 2023 | 19.34 Mn |
| Sep 30, 2023 | 24.56 Mn |
| Jun 30, 2023 | 14.42 Mn |
| Mar 31, 2023 | 13.93 Mn |
| Dec 31, 2022 | 18.26 Mn |
API Access
Eupraxia Pharmaceuticals Ending Cash Balance API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=EPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ending-cash-balance", "ticker": "EPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=EPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();